Community Level Interventions to Improve Minority Health (R01)
Recurring deadlines. Clinical trials optional.
Recurring deadlines. Clinical trials optional.
Recurring deadlines. Covers behavioral, epi, and health services approaches.
Recurring deadlines. Clinical trial not allowed.
California program but open to all institutions. Anticipated deadline.
RWJF — verify post-2021 institutional eligibility. Anticipated deadline.
Pre-application LOI required Aug 6.
Deadline extended from Jun 15 to Jul 15. Implementation-focused — strongest fit for faculty with existing CDC country office or MOH partnerships.
R01 mechanism. Six NIH ICs participating. Recurring standard deadlines through Oct 2027. Expires Jan 2028.
R61/R33 phased mechanism. HEAL Initiative priority. Chronic pain comorbid with SUD also in scope. Recurring standard NIH deadlines through Feb 2029.
Recurring deadlines through 2027. Companion to PAR-25-377 (observational). Clinical trial required. Requires Latin American institutional partner.